Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1988 1
1990 1
1991 1
1997 1
2001 4
2002 2
2003 4
2004 2
2005 8
2006 5
2007 11
2008 31
2009 21
2010 7
2011 1
2012 1
2014 2
2015 2
2016 2
2018 1
2019 1
2020 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 18214051

103 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic significance of serum retinol, serum alpha-tocopherol, and urinary neopterin in patients with head and neck carcinoma treated with external beam radiation.
Holečková P, Krčmová L, Kalábová H, Kašparová M, Plíšek J, Pála M, Vítek P, Solichová D, Zezulová M, Studentová H, Melichar B. Holečková P, et al. Int J Vitam Nutr Res. 2012 Apr;82(2):77-84. doi: 10.1024/0300-9831/a000096. Int J Vitam Nutr Res. 2012. PMID: 23065832 Free article.
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
Pignata S, Breda E, Scambia G, Pisano C, Zagonel V, Lorusso D, Greggi S, De Vivo R, Ferrandina G, Gallo C, Perrone F. Pignata S, et al. Crit Rev Oncol Hematol. 2008 Jun;66(3):229-36. doi: 10.1016/j.critrevonc.2007.12.005. Epub 2008 Feb 1. Crit Rev Oncol Hematol. 2008. PMID: 18243011 Clinical Trial.
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
Alberts DS, Marth C, Alvarez RD, Johnson G, Bidzinski M, Kardatzke DR, Bradford WZ, Loutit J, Kirn DH, Clouser MC, Markman M; GRACES Clinical Trial Consortium. Alberts DS, et al. Gynecol Oncol. 2008 May;109(2):174-81. doi: 10.1016/j.ygyno.2008.01.005. Epub 2008 Mar 7. Gynecol Oncol. 2008. PMID: 18314182 Clinical Trial.
103 results